–
MBX Biosciences, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY22:
FY23:
−32.0
FY24:
−54.7
FY25:
−79.9
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−30.9
FY24:
−161
FY25:
−83.7
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
69.2
FY24:
234
FY25:
190
millions USD
FY22:
–
FY23:
6.31
FY24:
18.8
FY25:
25.9
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.6
FY23:
−32.1
FY24:
−55.6
FY25:
−81.9
All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.